Abstract:Background Hepatocellular carcinoma (HCC) is the second-highest cause of malignancy-related death worldwide, and many physiological and pathological processes, including cancer, are regulated by microRNAs (miRNAs). miR-193a-3p is an anti-oncogene that plays an important part in health and disease biology by interacting with specific targets and signals. Methods In vitro assays were performed to explore the influences of miR-193a-3p on the propagation and apoptosis of HCC cells. The sequencing data for HCC were obtained from The Cancer Genome Atlas (TCGA), and the expression levels of miR-193a-3p in HCC and non-HCC tissues were calculated. The differential expression of miR-193a-3p in HCC was presented as standardized mean difference (SMD) with 95% confidence intervals (CIs) in Stata SE. The impact of miR-193a-3p on the prognoses of HCC patients was determined by survival analysis. The potential targets of miR-193a-3p were then predicted using miRWalk 2.0 and subjected to enrichment analyses, including Gene Ontology (GO) annotation, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and Protein-Protein Interaction (PPI) network analysis. The interaction between miR-193a-3p and one predicted target, Cyclin D1 (CCND1), was verified by dual luciferase reporter assays and Pearson correlation analysis. Results MiR-193a-3p inhibited the propagation and facilitated the apoptosis of HCC cells in vitro. The pooled SMD indicated that miR-193a-3p had a low level of expression in HCC (SMD: −0.88, 95% CI [−2.36 −0.59]). Also, HCC patients with a higher level of miR-193a-3p expression tended to have a favorable overall survival (OS: HR = 0.7, 95% CI [0.43–1.13], P = 0.14). For the KEGG pathway analysis, the most related pathway was “proteoglycans in cancer”, while the most enriched GO term was “protein binding”. The dual luciferase reporter assays demonstrated the direct interaction between miR-193a-3p and CCND1, and the Pearson correlation analysis suggested that miR-193a-3p was negatively correlated with CCND1 in HCC tissues (R = − 0.154, P = 0.002). Conclusion miR-193a-3p could suppress proliferation and promote apoptosis by targeting CCND1 in HCC cells. Further, miR-193a-3p can be used as a promising biomarker for the diagnosis and treatment of HCC in the future.

Downregulated Expression of Mirna-130A-5p Aggravates Hepatoma Progression Via Targeting PTP4A2

MicroRNA‐122 Suppresses Cell Proliferation and Induces Cell Apoptosis in Hepatocellular Carcinoma by Directly Targeting Wnt/β‐catenin Pathway

MicroRNA-130b Promotes Cell Aggressiveness by Inhibiting Peroxisome Proliferator-Activated Receptor Gamma in Human Hepatocellular Carcinoma

MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling

Mir-1307-3p Promotes Tumor Growth and Metastasis of Hepatocellular Carcinoma by Repressing DAB2 Interacting Protein.

[The Expression and Clinopathological Significance of Mir-130B in Human Hepatocellular Carcinoma].

MicroRNA-130a is Down-Regulated in Hepatocellular Carcinoma and Associates with Poor Prognosis

Mir-130a Regulates The Proliferation And Metastasis Of Hcc Cells Through Targeting Zeb1/2

Mir-532-3p Promotes Hepatocellular Carcinoma Progression by Targeting PTPRT.

Hypoxia-driven miR-1307-3p promotes hepatocellular carcinoma cell proliferation and invasion by modulating DAB2 interacting protein

Microrna-155-5p Promotes Hepatocellular Carcinoma Progression by Suppressing Pten Through the Pi3k/Akt Pathway

Downregulation of Mir-193A-3p is Involved in the Pathogenesis of Hepatocellular Carcinoma by Targeting CCND1

Over-expression of MiR-122 Promotes Apoptosis of Hepatocellular Carcinoma Via Targeting TLR4

miR-1307 promotes hepatocarcinogenesis by CALR-OSTC-endoplasmic reticulum protein folding pathway

Mir-206 Inhibits Cell Proliferation, Invasion, and Migration by Down-Regulating PTP1B in Hepatocellular Carcinoma.

MiR-130 Exerts Tumor Suppressive Function on the Tumorigenesis of Human Non-Small Cell Lung Cancer by Targeting PTEN.

Mir-1204 Promotes Hepatocellular Carcinoma Progression Through Activating MAPK and C-Jun/ap1 Signaling by Targeting ZNF418

Mir-106B-5p Promotes Stem Cell-Like Properties of Hepatocellular Carcinoma Cells by Targeting PTEN Via PI3K/Akt Pathway

MicroRNA-18a Promotes Hepatocellular Carcinoma Proliferation, Migration, and Invasion by Targeting Bcl2L10

MiR-103a Promotes Tumour Growth and Influences Glucose Metabolism in Hepatocellular Carcinoma

Decreased Expression of Hepatocyte Nuclear Factor 4α (Hnf4α)/microrna-122 (Mir-122) Axis in Hepatitis B Virus-associated Hepatocellular Carcinoma Enhances Potential Oncogenic GALNT10 Protein Activity